pyrazines has been researched along with Anochlesia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, H; Conlon, PR; Engber, TM; Haque, S; Kiesman, WF; Kumaravel, G; Petter, RC; Sha, L; Wang, J; Whalley, ET; Yao, G | 1 |
Brown, J; Chapin, DS; Chiang, P; Guanowsky, V; Iredale, PA; Marala, R; McCarthy, SA; Patterson, T; Seymour, PA; Siuciak, JA; Swick, A | 1 |
2 other study(ies) available for pyrazines and Anochlesia
Article | Year |
---|---|
Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists.
Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Alkynes; Animals; Catalepsy; Cerebral Cortex; Disease Models, Animal; Mice; Oxidopamine; Parkinson Disease; Pyrazines; Rats; Structure-Activity Relationship; Triazoles | 2005 |
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
Topics: Amphetamines; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Helplessness, Learned; Humans; Hyperkinesis; Inhibition, Psychological; Male; Mice; Motor Activity; NIH 3T3 Cells; Piperazines; Protein Binding; Psychotic Disorders; Pyrazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists | 2007 |